MedGreen Pharmaceutical aspires to be the leading phytopharmaceutical company to advance the science of Cannabis medicines globally. We’ve committed to a research programme focusing on how New Zealand-grown cannabis can be used to treat a range of acute and chronic conditions such as Anxiety, Post-Traumatic Stress Disorder, Neuropathic Pain conditions, Cancers, Neurologic conditions, Skin Disorders, Autoimmune conditions, Gastrointestinal conditions and others.
Through an array of clinical trials, observational studies and pharmacokinetic studies, MedGreen is developing new scientific evidence to support the development of safe, effective medical cannabis products and bringing more understanding to the public and healthcare professionals about the safe, effective and health promoting use of these medicines.